DME
Clinical trials for DME explained in plain language.
Never miss a new study
Get alerted when new DME trials appear
Sign up with your email to follow new studies for DME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for diabetic eye disease: experimental drug SNP318 enters Mid-Stage trial
Disease control Not yet recruitingThis study tests an experimental drug called SNP318 in 60 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the retina. The goal is to see if the drug is safe and can improve vision or reduce swelling compared to a placebo. Participa…
Matched conditions: DME
Phase: PHASE2 • Sponsor: SciNeuro • Aim: Disease control
Last updated May 17, 2026 08:55 UTC
-
New daily pill aims to ease diabetic eye swelling
Disease control Not yet recruitingThis study tests an oral medication, CU06-1004, taken once daily for 24 weeks in about 156 people with diabetic macular edema (DME), a condition that causes vision loss due to swelling in the center of the retina. Participants are randomly assigned to receive a low dose, a high d…
Matched conditions: DME
Phase: PHASE2 • Sponsor: Curacle Co., Ltd. • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
AI eye doctor: new system aims to take guesswork out of injection timing
Knowledge-focused Not yet recruitingThis study tests an AI system called FM-VEGF-CDSS that helps doctors decide the best time for anti-VEGF eye injections in people with wet age-related macular degeneration, diabetic macular edema, or retinal vein occlusion. The AI looks at eye scans and medical records to suggest …
Matched conditions: DME
Phase: NA • Sponsor: Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine • Aim: Knowledge-focused
Last updated May 14, 2026 12:05 UTC